Onderneming Haleon plc

HLN

GB00BMX86B70

Farmaceutische producten

Analistenconsensus

Vakgebied

Verkoop per activiteit

Verkoop per regio

Managers

Besturend

Aandelenklasse

Aandeelhouders

Bedrijfsgegevens

Bedrijven van de groep

Sector

Verkoop per activiteit

Verkoop per regio

Ratings voor Haleon plc

Herzieningen van WPA

Kwartaalwinst - Afwijkingspercentage

Sector Farmaceutische producten - Andere

Geschatte realtime Cboe Europe Andere beurzen 09:36:46 26-04-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
334 ^GBX	+0,77%		+2,67%	+4,00%

25/04	Moody's bevestigt de ratings van Haleon op basis van sterke operationele prestaties	MT
24/04	Haleon benoemt Tate & Lyle's financieel directeur als CFO vanaf november	AN

Haleon plc is gespecialiseerd in onderzoek, productie en marketing van geneesmiddelen en farmaceutische consumentenproducten. De netto-omzet is als volgt over de productfamilie verdeeld:
- mondverzorgingsproducten (27,7%; nr. 1 wereldwijd): Sensodyne, Parodontax, Polident, Biotene, Aquafresh-merken, enz;
- Geneesmiddelen tegen pijn (23,5%; wereldwijd nr. 1): Panadol, Advil, Voltaren, Excedrin merken, enz;
- Geneesmiddelen voor een gezonde spijsvertering (18,9%; wereldwijd nr. 1): TUMS, Nicorette, ENO, Chap Stick, Fenistil, Nexium merken, enz;
- geneesmiddelen voor de luchtwegen (15,4%; wereldwijd nr. 1): Theraflu, Otrivin, Flonase, Contac merken, enz;
- vitaminen, mineralen en voedingssupplementen (14,5%; wereldwijd nr. 1): Centrum, Emergen-C, Caltrate merken, enz.
De netto-omzet is geografisch als volgt verdeeld: Europa/Midden-Oosten/Afrika/Latijns-Amerika (40,2%), Noord-Amerika (37,1%) en Azië/Pacific (22,7%).

Aantal werknemers: 25 408

GBP in miljoen	2022	Gewicht	2023	Gewicht	Delta
Oral Health 27,7 %	2 957	27,2 %	3 136	27,7 %	+6,05%
Pain Relief 23,5 %	2 551	23,5 %	2 652	23,5 %	+3,96%
Digestive Health and Other 18,9 %	2 096	19,3 %	2 138	18,9 %	+2,00%
Respiratory Health 15,4 %	1 579	14,5 %	1 736	15,4 %	+9,94%
Vitamins, Minerals and Supplements 14,5 %	1 675	15,4 %	1 640	14,5 %	-2,09%

GBP in miljoen	2022	Gewicht	2023	Gewicht	Delta
EMEA and Latin America 40,2 %	4 270	39,3 %	4 545	40,2 %	+6,44%
North America 37,1 %	4 116	37,9 %	4 195	37,1 %	+1,92%
APAC 22,7 %	2 472	22,8 %	2 562	22,7 %	+3,64%

Managers	Titel	Leeftijd	Van
Brian McNamara CEO	Chief Executive Officer	57	22-07-21
Tobias Hestler DFI	Director of Finance/CFO	52	01-12-21
Franck Riot CTO	Chief Tech/Sci/R&D Officer	-	16-12-21
Sonya Ghobrial IRC	Investor Relations Contact	-	-
Tamara Rogers SAM	Sales & Marketing	-	16-12-21
Lisa Paley PRN	Corporate Officer/Principal	-	-
Keith Choy PRN	Corporate Officer/Principal	-	-
Filippo Lanzi PRN	Corporate Officer/Principal	-	-
Mairéad Nayager HRO	Human Resources Officer	-	01-03-22
Bjarne Tellmann LAW	General Counsel	57	16-12-21

Besturend	Titel	Leeftijd	Van
Bryan Supran BRD	Director/Board Member	-	18-07-22
Dame Cox BRD	Director/Board Member	63	18-07-22
Tracy Clarke BRD	Director/Board Member	57	18-07-22
Vindi Banga BRD	Director/Board Member	69	18-07-22
Deirdre Mahlan BRD	Director/Board Member	61	18-07-22
David Lewis CHM	Chairman	59	23-05-22
David Denton BRD	Director/Board Member	59	01-03-23
Tobias Hestler DFI	Director of Finance/CFO	52	01-12-21
Brian McNamara CEO	Chief Executive Officer	57	22-07-21
Marie-Anne Aymerich BRD	Director/Board Member	-	18-07-22

	Stemming	Aantal	Vrij verhandelbaar	Bedrijfseigen aandelen	Drijvend Totaal
Aandeel A	1	9 132 301 104	7 072 820 336 ( 77,45 %)	0	77,45 %

Naam	Aandelen	%	Totale waarde
PFIZER, INC. 32,36 %	2 955 063 626	32,36 %	12 435 M p
GSK PLC 4,219 %	385 320 110	4,219 %	1 621 M p
The Vanguard Group, Inc. 1,790 %	163 500 000	1,790 %	688 M p
Dodge & Cox 1,733 %	158 253 000	1,733 %	666 M p
Norges Bank Investment Management 1,621 %	148 004 000	1,621 %	623 M p
MFS International (UK) Ltd. 1,357 %	123 903 066	1,357 %	521 M p
GIC Pte Ltd. (Investment Management) 1,045 %	95 442 000	1,045 %	402 M p
BlackRock Advisors (UK) Ltd. 0,9963 %	90 981 000	0,9963 %	383 M p
BlackRock Investment Management (UK) Ltd. 0,7176 %	65 536 000	0,7176 %	276 M p
FIL Investment Advisors (UK) Ltd. 0,5522 %	50 431 000	0,5522 %	212 M p

Naam	Aandelen	%	Totale waarde
Dodge & Cox 2,424 %	110 663 098	2,424 %	940 M p
Fidelity Management & Research Co. LLC 1,399 %	63 897 244	1,399 %	542 M p
ClearBridge Investments LLC 0,5822 %	26 581 902	0,5822 %	226 M p
Harding Loevner LP 0,4900 %	22 372 190	0,4900 %	190 M p
Fisher Asset Management LLC 0,3228 %	14 737 776	0,3228 %	125 M p
Wellington Management Co. LLP 0,2966 %	13 542 346	0,2966 %	115 M p
AllianceBernstein LP 0,2396 %	10 939 898	0,2396 %	93 M p
Aristotle Capital Management LLC 0,1950 %	8 905 038	0,1950 %	76 M p
Merrill Lynch International 0,1843 %	8 414 511	0,1843 %	71 M p
Douglas Lane & Associates LLC 0,1840 %	8 401 876	0,1840 %	71 M p

Haleon Plc

The Heights Building 5, 1st Floor

KT13 0NY, Weybridge

+44 1932 822000

http://www.haleon.com

Naam	Categorie en sector
GlaxoSmithKline Consumer Pvt Ltd. GlaxoSmithKline Consumer Pvt Ltd. Pharmaceuticals: MajorHealth Technology Part of GSK Plc, GlaxoSmithKline Consumer Pvt Ltd. is an Indian company that develops, manufactures, and distributes vaccines and other pharmaceutical products. The private company is based in Patiala, India and was founded in 2014.	Pharmaceuticals: Major
GlaxoSmithKline Consumer Healthcare Finance Ltd. GlaxoSmithKline Consumer Healthcare Finance Ltd. Financial ConglomeratesFinance Founded in 2014, GlaxoSmithKline Consumer Healthcare Finance Ltd. is a British company that provides investment services. Part of GSK Plc, the private company is based in Brentford, UK.	Financial Conglomerates
GlaxoSmithKline Consumer Healthcare Holdings Ltd. GlaxoSmithKline Consumer Healthcare Holdings Ltd. Financial ConglomeratesFinance Part of GSK Plc, GlaxoSmithKline Consumer Healthcare Holdings Ltd. functions as an investment holding British company. The private company is based in Brentford, UK.	Financial Conglomerates
GlaxoSmithKline Consumer Healthcare (Overseas) Ltd. GlaxoSmithKline Consumer Healthcare (Overseas) Ltd. Financial ConglomeratesFinance Part of GSK Plc, GlaxoSmithKline Consumer Healthcare (Overseas) Ltd. is a British company that offers Voltarol patches and plasters for effective pain relief. The private company is based in Brentford, UK. The text from the 'description' mentions that Voltarol offers different kinds of patches and plasters for pain relief and provides information on common causes of foot and ankle pain. The company was founded in 2014.	Financial Conglomerates
Haleon UK Trading Services Ltd. Haleon UK Trading Services Ltd. Drugstore ChainsRetail Trade Part of Haleon Uk Holdings (No. 3) Ltd., Haleon UK Trading Services Ltd. is a wholesaler of pharmaceutical goods. The private company is based in Weybridge, UK. Founded in 2012.	Drugstore Chains
GSK Consumer Healthcare Capital US LLC GSK Consumer Healthcare Capital US LLC Medical/Nursing ServicesHealth Services Part of Haleon Plc, Haleon US Capital LLC is a private company that provides healthcare services. Haleon US Capital LLC is based in Wilmington, DE.	Medical/Nursing Services
Haleon UK Capital Plc Haleon UK Capital Plc Regional BanksFinance Part of Haleon Plc, Haleon UK Capital Plc is a financial intermediation company. Haleon UK Capital Plc is based in Middlesex, UK. The British company was founded in 2021. The CEO is Brian James McNamara.	Regional Banks
Gsk Consumer Healthcare Capital Nl BV Gsk Consumer Healthcare Capital Nl BV Pharmaceuticals: OtherHealth Technology Part of Haleon Plc, Haleon Netherlands Capital BV is a British company that manufactures medicinal and botanicals. The private company is located in the UK.	Pharmaceuticals: Other

Trading rating

Beleggingsrating

ESG Refinitiv

Meer adviezen

Verkoop

Koop

Gemiddeld advies

Accumuleren

Aantal analisten

Laatste slotkoers

3,315 GBP

Gemiddelde koersdoel

3,594 GBP

Spread / Gemiddelde doel

+8,41%

Consensus

Bedrijfscijfers

De agenda van het bedrijf

Gezondheidszorg

Farmaceutisch en medisch onderzoek

Farmaceutische producten

Farmaceutische producten

Farmaceutische producten - Andere

	Vaira. 1 jan.	Kapi.
HALEON PLC	+4,00%	37,83 mld.
NOVO NORDISK A/S	+25,11%	556 mld.
JOHNSON & JOHNSON	-6,33%	354 mld.
MERCK & CO., INC.	+19,90%	331 mld.
ABBVIE INC.	+7,95%	296 mld.
ASTRAZENECA PLC	+13,58%	233 mld.
NOVARTIS AG	+5,94%	201 mld.
ROCHE HOLDING AG	-9,90%	193 mld.
PFIZER, INC.	-12,26%	143 mld.
AMGEN INC.	-6,47%	144 mld.

Farmaceutische producten - Andere